490 related articles for article (PubMed ID: 26189185)
1. Multidrug-Resistant Pseudomonas aeruginosa Keratitis: Risk Factors, Clinical Characteristics, and Outcomes.
Vazirani J; Wurity S; Ali MH
Ophthalmology; 2015 Oct; 122(10):2110-4. PubMed ID: 26189185
[TBL] [Abstract][Full Text] [Related]
2. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
Fernandes M; Vira D; Medikonda R; Kumar N
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):315-22. PubMed ID: 26537122
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
Cho CH; Lee SB
BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of corneal graft infections caused by multi-drug resistant Pseudomonas aeruginosa.
Jain R; Murthy SI; Motukupally SR
Cornea; 2014 Jan; 33(1):22-6. PubMed ID: 24240490
[TBL] [Abstract][Full Text] [Related]
5. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.
Jain R; Murthy SI; Motukupally SR; Jain M
Cornea; 2014 Sep; 33(9):923-7. PubMed ID: 25014142
[TBL] [Abstract][Full Text] [Related]
6. Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.
Chatterjee S; Agrawal D
Indian J Ophthalmol; 2016 Feb; 64(2):153-7. PubMed ID: 27050354
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and causative organisms in microbial keratitis.
Green M; Apel A; Stapleton F
Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
[TBL] [Abstract][Full Text] [Related]
8. An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
Knoester M; de Boer MG; Maarleveld JJ; Claas EC; Bernards AT; de Jonge E; van Dissel JT; Veldkamp KE
Clin Microbiol Infect; 2014 Apr; 20(4):O207-15. PubMed ID: 24707852
[TBL] [Abstract][Full Text] [Related]
9. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
[TBL] [Abstract][Full Text] [Related]
10. [Contact lens related corneal ulcers: clinical, microbiological and therapeutic features].
Benhmidoune L; Bensemlali A; Bouazza M; Karami R; El Mansouri H; El Belhadji M; Rachid R; Chakib A; Amraoui A
J Fr Ophtalmol; 2013 Sep; 36(7):594-9. PubMed ID: 23790567
[TBL] [Abstract][Full Text] [Related]
11. Multiresistant Pseudomonas keratitis.
Ku JY; Kim P; Tong J; Wechsler A; McCluskey P
Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829
[No Abstract] [Full Text] [Related]
12. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
13. Genetic features of Pseudomonas aeruginosa isolates associated with eye infections referred to Farabi Hospital, Tehran, Iran.
Doustdar F; Karimi F; Abedinyfar Z; Amoli FA; Goudarzi H
Int Ophthalmol; 2019 Jul; 39(7):1581-1587. PubMed ID: 29982958
[TBL] [Abstract][Full Text] [Related]
14. Risk factors in microbial keratitis leading to penetrating keratoplasty.
Miedziak AI; Miller MR; Rapuano CJ; Laibson PR; Cohen EJ
Ophthalmology; 1999 Jun; 106(6):1166-70; discussion 1171. PubMed ID: 10366087
[TBL] [Abstract][Full Text] [Related]
15. Bacterial keratitis in a tertiary eye centre in Iran: a retrospective study.
Rahimi F; Hashemian MN; Khosravi A; Moradi G; Bamdad S
Middle East Afr J Ophthalmol; 2015; 22(2):238-44. PubMed ID: 25949085
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Pseudomonas aeruginosa genotype with antibiotic susceptibility and clinical features of induced central keratitis.
Shen EP; Hsieh YT; Chu HS; Chang SC; Hu FR
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):365-71. PubMed ID: 25537202
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
Aloush V; Navon-Venezia S; Seigman-Igra Y; Cabili S; Carmeli Y
Antimicrob Agents Chemother; 2006 Jan; 50(1):43-8. PubMed ID: 16377665
[TBL] [Abstract][Full Text] [Related]
19. Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania.
Ni N; Nam EM; Hammersmith KM; Nagra PK; Azari AA; Leiby BE; Dai Y; Cabrera FA; Ma JF; Lambert CE; Honig SE; Rapuano CJ
Cornea; 2015 Mar; 34(3):296-302. PubMed ID: 25603231
[TBL] [Abstract][Full Text] [Related]
20. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Lodise TP; Miller CD; Graves J; Furuno JP; McGregor JC; Lomaestro B; Graffunder E; McNutt LA
Antimicrob Agents Chemother; 2007 Feb; 51(2):417-22. PubMed ID: 17158943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
